Our group company, Axcelead Drug Discovery Partners, Inc. (“Axcelead DDP”), has entered into a drug discovery service agreement with Astellas Pharma, Inc. to explore new candidate compounds for targeted protein degraders.

For more information, please see the Axcelead DDP news release.